Thrombocytopenia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 11: Line 11:
!Disease
!Disease
!History and symptoms
!History and symptoms
!Laboratory findings
! colspan="3" |Laboratory findings
!Pathology
!Pathology
|-
|
|
|
|WBC changes
|RBC changes
|other findings
|
|-
|-
| rowspan="2" |'''Cardiovascular'''
| rowspan="2" |'''Cardiovascular'''
|[[endocarditis]]
|[[endocarditis]]
|
|
|
|
|
|
Line 21: Line 31:
|-
|-
|[[pulmonary embolism]]
|[[pulmonary embolism]]
|
|
|
|
|
|
Line 27: Line 39:
| rowspan="2" |'''Chemical/poisoning'''
| rowspan="2" |'''Chemical/poisoning'''
|[[Strontium-89]]
|[[Strontium-89]]
|
|
|
|
|
|
Line 32: Line 46:
|-
|-
|[[zinc]]
|[[zinc]]
|
|
|
|
|
|
Line 38: Line 54:
| rowspan="4" |'''Dermatologic'''
| rowspan="4" |'''Dermatologic'''
|[[Cholesterol embolism]]
|[[Cholesterol embolism]]
|
|
|
|
|
|
Line 43: Line 61:
|-
|-
|[[Elejalde syndrome]]
|[[Elejalde syndrome]]
|
|
|
|
|
|
Line 48: Line 68:
|-
|-
|[[Griscelli syndrome|Griscelli syndrome type 1]]
|[[Griscelli syndrome|Griscelli syndrome type 1]]
|
|
|
|
|
|
Line 53: Line 75:
|-
|-
|[[neuroectodermal melanolysosomal disease]]
|[[neuroectodermal melanolysosomal disease]]
|
|
|
|
|
|
Line 59: Line 83:
| rowspan="4" |'''Ear Nose Throat'''
| rowspan="4" |'''Ear Nose Throat'''
|[[Alport syndrome]]
|[[Alport syndrome]]
|
|
|
|
|
|
Line 64: Line 90:
|-
|-
|Arias oculootoradial syndrome
|Arias oculootoradial syndrome
|
|
|
|
|
|
Line 69: Line 97:
|-
|-
|[[Epstein's syndrome]]
|[[Epstein's syndrome]]
|
|
|
|
|
|
Line 74: Line 104:
|-
|-
|[[Fechtner syndrome]]
|[[Fechtner syndrome]]
|
|
|
|
|
|
Line 80: Line 112:
|'''Endocrine'''
|'''Endocrine'''
|[[Immunodysregulation polyendocrinopathy and enteropathy, X-linked]]
|[[Immunodysregulation polyendocrinopathy and enteropathy, X-linked]]
|
|
|
|
|
|
Line 86: Line 120:
| rowspan="4" |'''Gastroenterologic'''
| rowspan="4" |'''Gastroenterologic'''
|[[Aminoaciduria|Dibasic aminoaciduria type 2]]
|[[Aminoaciduria|Dibasic aminoaciduria type 2]]
|
|
|
|
|
|
Line 91: Line 127:
|-
|-
|[[liver failure]]
|[[liver failure]]
|
|
|
|
|
|
Line 96: Line 134:
|-
|-
|[[Niemann-Pick disease|Niemann-Pick disease type b]]
|[[Niemann-Pick disease|Niemann-Pick disease type b]]
|
|
|
|
|
|
Line 101: Line 141:
|-
|-
|[[portal hypertension]]
|[[portal hypertension]]
|
|
|
|
|
|
Line 107: Line 149:
| rowspan="14" |'''Genetic'''
| rowspan="14" |'''Genetic'''
|[[Aicardi-Goutieres syndrome]]
|[[Aicardi-Goutieres syndrome]]
|
|
|
|
|
|
Line 112: Line 156:
|-
|-
|[[Chediak-Higashi disease]]
|[[Chediak-Higashi disease]]
|
|
|
|
|
|
Line 117: Line 163:
|-
|-
|[[Factor H|complement factor H deficiency]]
|[[Factor H|complement factor H deficiency]]
|
|
|
|
|
|
Line 122: Line 170:
|-
|-
|[[Elejalde syndrome]]
|[[Elejalde syndrome]]
|
|
|
|
|
|
Line 127: Line 177:
|-
|-
|[[Fanconi anaemia]]
|[[Fanconi anaemia]]
|
|
|
|
|
|
Line 132: Line 184:
|-
|-
|[[Fechtner syndrome]]
|[[Fechtner syndrome]]
|
|
|
|
|
|
Line 137: Line 191:
|-
|-
|[[Griscelli syndrome|Griscelli syndrome type 1]]
|[[Griscelli syndrome|Griscelli syndrome type 1]]
|
|
|
|
|
|
Line 142: Line 198:
|-
|-
|[[holocarboxylase synthase deficiency]]
|[[holocarboxylase synthase deficiency]]
|
|
|
|
|
|
Line 147: Line 205:
|-
|-
|[[iminodipeptiduria]]
|[[iminodipeptiduria]]
|
|
|
|
|
|
Line 152: Line 212:
|-
|-
|[[Jacobsen syndrome]]
|[[Jacobsen syndrome]]
|
|
|
|
|
|
Line 157: Line 219:
|-
|-
|[[MELAS]]
|[[MELAS]]
|
|
|
|
|
|
Line 162: Line 226:
|-
|-
|[[Omenn syndrome]]
|[[Omenn syndrome]]
|
|
|
|
|
|
Line 167: Line 233:
|-
|-
|[[TAR syndrome]]
|[[TAR syndrome]]
|
|
|
|
|
|
Line 172: Line 240:
|-
|-
|[[X-linked hyperimmunoglobulin M syndrome]]
|[[X-linked hyperimmunoglobulin M syndrome]]
|
|
|
|
|
|
Line 178: Line 248:
| rowspan="33" |'''Hematologic'''
| rowspan="33" |'''Hematologic'''
|[[Acquired pure megakaryocytic aplasia]]
|[[Acquired pure megakaryocytic aplasia]]
|
|
|
|
|
|
Line 183: Line 255:
|-
|-
|[[aplastic anemia]]
|[[aplastic anemia]]
|
|
|
|
|
|
Line 188: Line 262:
|-
|-
|[[Bernard-Soulier syndrome]]
|[[Bernard-Soulier syndrome]]
|
|
|
|
|
|
Line 193: Line 269:
|-
|-
|[[Thrombocytopenia|congenital amegakaryocytic thrombocytopenia (CAMT)]]
|[[Thrombocytopenia|congenital amegakaryocytic thrombocytopenia (CAMT)]]
|
|
|
|
|
|
Line 198: Line 276:
|-
|-
|[[disseminated intravascular coagulation]]
|[[disseminated intravascular coagulation]]
|
|
|
|
|
|
Line 203: Line 283:
|-
|-
|[[Epstein's syndrome]]
|[[Epstein's syndrome]]
|
|
|
|
|
|
Line 208: Line 290:
|-
|-
|[[familial histiocytic reticulosis]]
|[[familial histiocytic reticulosis]]
|
|
|
|
|
|
Line 213: Line 297:
|-
|-
|[[Gasser syndrome]]
|[[Gasser syndrome]]
|
|
|
|
|
|
Line 218: Line 304:
|-
|-
|[[GATA1|GATA1-related cytopenia]]
|[[GATA1|GATA1-related cytopenia]]
|
|
|
|
|
|
Line 223: Line 311:
|-
|-
|[[Glanzmann's thrombasthenia]]
|[[Glanzmann's thrombasthenia]]
|
|
|
|
|
|
Line 228: Line 318:
|-
|-
|[[grey platelet syndrome]]
|[[grey platelet syndrome]]
|
|
|
|
|
|
Line 233: Line 325:
|-
|-
|[[hemolytic uremic syndrome]]
|[[hemolytic uremic syndrome]]
|
|
|
|
|
|
Line 238: Line 332:
|-
|-
|[[histiocytosis X]]
|[[histiocytosis X]]
|
|
|
|
|
|
Line 243: Line 339:
|-
|-
|[[hypersplenism]]
|[[hypersplenism]]
|
|
|
|
|
|
Line 248: Line 346:
|-
|-
|[[idiopathic thrombocytopenic purpura]]
|[[idiopathic thrombocytopenic purpura]]
|
|
|
|
|
|
Line 253: Line 353:
|-
|-
|[[Jacobsen syndrome]]
|[[Jacobsen syndrome]]
|
|
|
|
|
|
Line 258: Line 360:
|-
|-
|[[Kasabach-Merritt syndrome]]
|[[Kasabach-Merritt syndrome]]
|
|
|
|
|
|
Line 263: Line 367:
|-
|-
|[[May-Hegglin anomaly]]
|[[May-Hegglin anomaly]]
|
|
|
|
|
|
Line 268: Line 374:
|-
|-
|[[Moschcowitz syndrome]]
|[[Moschcowitz syndrome]]
|
|
|
|
|
|
Line 273: Line 381:
|-
|-
|[[myelodysplastic syndrome]]
|[[myelodysplastic syndrome]]
|
|
|
|
|
|
Line 278: Line 388:
|-
|-
|[[myelofibrosis]]
|[[myelofibrosis]]
|
|
|
|
|
|
Line 283: Line 395:
|-
|-
|[[neonatal alloimmune thrombocytopenia]]
|[[neonatal alloimmune thrombocytopenia]]
|
|
|
|
|
|
Line 288: Line 402:
|-
|-
|[[pancytopenia]]
|[[pancytopenia]]
|
|
|
|
|
|
Line 293: Line 409:
|-
|-
|Paris-Trousseau thrombocytopenia
|Paris-Trousseau thrombocytopenia
|
|
|
|
|
|
Line 298: Line 416:
|-
|-
|[[paroxysmal nocturnal hemoglobinuria]]
|[[paroxysmal nocturnal hemoglobinuria]]
|
|
|
|
|
|
Line 303: Line 423:
|-
|-
|[[post-transfusion purpura]]
|[[post-transfusion purpura]]
|
|
|
|
|
|
Line 308: Line 430:
|-
|-
|[[TAR syndrome|radial aplasia-thrombocytopenia syndrome]]
|[[TAR syndrome|radial aplasia-thrombocytopenia syndrome]]
|
|
|
|
|
|
Line 313: Line 437:
|-
|-
|[[Sebastian platelet syndrome]]
|[[Sebastian platelet syndrome]]
|
|
|
|
|
|
Line 318: Line 444:
|-
|-
|[[Shwachman-Diamond syndrome]]
|[[Shwachman-Diamond syndrome]]
|
|
|
|
|
|
Line 323: Line 451:
|-
|-
|[[thrombotic thrombocytopenic purpura]]
|[[thrombotic thrombocytopenic purpura]]
|
|
|
|
|
|
Line 328: Line 458:
|-
|-
|[[Von Willebrand disease|Von Willebrand disease, platelet type]]
|[[Von Willebrand disease|Von Willebrand disease, platelet type]]
|
|
|
|
|
|
Line 333: Line 465:
|-
|-
|[[Werlhof disease]]
|[[Werlhof disease]]
|
|
|
|
|
|
Line 338: Line 472:
|-
|-
|[[Wiskott-Aldrich syndrome]]
|[[Wiskott-Aldrich syndrome]]
|
|
|
|
|
|
Line 344: Line 480:
| rowspan="5" |'''Iatrogenic'''
| rowspan="5" |'''Iatrogenic'''
|[[Coronary artery bypass surgery|Cardiac bypass]]
|[[Coronary artery bypass surgery|Cardiac bypass]]
|
|
|
|
|
|
Line 349: Line 487:
|-
|-
|[[chemotherapy]]
|[[chemotherapy]]
|
|
|
|
|
|
Line 354: Line 494:
|-
|-
|[[Intra-aortic balloon pump|intra-aortic balloon pump placement]]
|[[Intra-aortic balloon pump|intra-aortic balloon pump placement]]
|
|
|
|
|
|
Line 359: Line 501:
|-
|-
|[[Blood transfusion|massive blood transfusion]]
|[[Blood transfusion|massive blood transfusion]]
|
|
|
|
|
|
Line 364: Line 508:
|-
|-
|[[radiation therapy]]
|[[radiation therapy]]
|
|
|
|
|
|
Line 370: Line 516:
| rowspan="25" |'''Infectious diseases'''
| rowspan="25" |'''Infectious diseases'''
|[[Congenital syphilis]]
|[[Congenital syphilis]]
|
|
|
|
|
|
Line 375: Line 523:
|-
|-
|[[cytomegalovirus]]
|[[cytomegalovirus]]
|
|
|
|
|
|
Line 380: Line 530:
|-
|-
|[[Dengue fever]]
|[[Dengue fever]]
|
|
|
|
|
|
Line 385: Line 537:
|-
|-
|[[ehrlichiosis]]
|[[ehrlichiosis]]
|
|
|
|
|
|
Line 390: Line 544:
|-
|-
|[[Epstein-Barr virus]]
|[[Epstein-Barr virus]]
|
|
|
|
|
|
Line 395: Line 551:
|-
|-
|[[hantavirus]]
|[[hantavirus]]
|
|
|
|
|
|
Line 400: Line 558:
|-
|-
|[[hepatitis C]]
|[[hepatitis C]]
|
|
|
|
|
|
Line 405: Line 565:
|-
|-
|[[HIV]]
|[[HIV]]
|
|
|
|
|
|
Line 410: Line 572:
|-
|-
|[[human granulocytic ehrlichiosis]]
|[[human granulocytic ehrlichiosis]]
|
|
|
|
|
|
Line 415: Line 579:
|-
|-
|[[Ehrlichiosis|human monocytotropic ehrlichiosis]]
|[[Ehrlichiosis|human monocytotropic ehrlichiosis]]
|
|
|
|
|
|
Line 420: Line 586:
|-
|-
|[[lassa fever]]
|[[lassa fever]]
|
|
|
|
|
|
Line 425: Line 593:
|-
|-
|[[leptospirosis]]
|[[leptospirosis]]
|
|
|
|
|
|
Line 430: Line 600:
|-
|-
|[[malaria]]
|[[malaria]]
|
|
|
|
|
|
Line 435: Line 607:
|-
|-
|[[measles]]
|[[measles]]
|
|
|
|
|
|
Line 440: Line 614:
|-
|-
|[[mumps]]
|[[mumps]]
|
|
|
|
|
|
Line 445: Line 621:
|-
|-
|[[mycoplasma pneumonia]]
|[[mycoplasma pneumonia]]
|
|
|
|
|
|
Line 450: Line 628:
|-
|-
|[[Relapsing fever|Oklahoma tick fever]]
|[[Relapsing fever|Oklahoma tick fever]]
|
|
|
|
|
|
Line 455: Line 635:
|-
|-
|[[parvovirus]]
|[[parvovirus]]
|
|
|
|
|
|
Line 460: Line 642:
|-
|-
|[[Q fever]]
|[[Q fever]]
|
|
|
|
|
|
Line 465: Line 649:
|-
|-
|[[rubella]]
|[[rubella]]
|
|
|
|
|
|
Line 470: Line 656:
|-
|-
|sepsis
|sepsis
|
|
|
|
|
|
Line 475: Line 663:
|-
|-
|[[tick-borne encephalitis]]
|[[tick-borne encephalitis]]
|
|
|
|
|
|
Line 480: Line 670:
|-
|-
|[[Toxic shock syndrome|toxic shock syndrome (staphylococcal)]]
|[[Toxic shock syndrome|toxic shock syndrome (staphylococcal)]]
|
|
|
|
|
|
Line 485: Line 677:
|-
|-
|[[varicella]]
|[[varicella]]
|
|
|
|
|
|
Line 490: Line 684:
|-
|-
|[[visceral leishmaniasis]]
|[[visceral leishmaniasis]]
|
|
|
|
|
|
Line 496: Line 692:
| rowspan="14" |'''Nutritional/Metabolic'''
| rowspan="14" |'''Nutritional/Metabolic'''
|[[folate deficiency]]
|[[folate deficiency]]
|
|
|
|
|
|
Line 501: Line 699:
|-
|-
|[[Gaucher disease]]
|[[Gaucher disease]]
|
|
|
|
|
|
Line 506: Line 706:
|-
|-
|[[holocarboxylase synthase deficiency]]
|[[holocarboxylase synthase deficiency]]
|
|
|
|
|
|
Line 511: Line 713:
|-
|-
|[[iminodipeptiduria]]
|[[iminodipeptiduria]]
|
|
|
|
|
|
Line 516: Line 720:
|-
|-
|[[iron deficiency]]
|[[iron deficiency]]
|
|
|
|
|
|
Line 521: Line 727:
|-
|-
|[[isovaleric acidaemia]]
|[[isovaleric acidaemia]]
|
|
|
|
|
|
Line 526: Line 734:
|-
|-
|[[Methylmalonic aciduria|methylmalonic aciduria type 2]]
|[[Methylmalonic aciduria|methylmalonic aciduria type 2]]
|
|
|
|
|
|
Line 531: Line 741:
|-
|-
|[[CD36|platelet glycoprotein 4 deficiency]]
|[[CD36|platelet glycoprotein 4 deficiency]]
|
|
|
|
|
|
Line 536: Line 748:
|-
|-
|[[platelet glycoprotein Ib deficiency]]
|[[platelet glycoprotein Ib deficiency]]
|
|
|
|
|
|
Line 541: Line 755:
|-
|-
|[[prolidase deficiency]]
|[[prolidase deficiency]]
|
|
|
|
|
|
Line 546: Line 762:
|-
|-
|[[propionyl-CoA carboxylase deficiency]]
|[[propionyl-CoA carboxylase deficiency]]
|
|
|
|
|
|
Line 551: Line 769:
|-
|-
|[[sea blue histiocytosis]]
|[[sea blue histiocytosis]]
|
|
|
|
|
|
Line 556: Line 776:
|-
|-
|[[sitosterolemia]]
|[[sitosterolemia]]
|
|
|
|
|
|
Line 561: Line 783:
|-
|-
|[[vitamin B12 deficiency]]
|[[vitamin B12 deficiency]]
|
|
|
|
|
|
Line 567: Line 791:
| rowspan="2" |'''Obstetric/Gynecologic'''
| rowspan="2" |'''Obstetric/Gynecologic'''
|[[Eclampsia]], [[pre-eclampsia]]
|[[Eclampsia]], [[pre-eclampsia]]
|
|
|
|
|
|
Line 572: Line 798:
|-
|-
|[[HELLP syndrome]]
|[[HELLP syndrome]]
|
|
|
|
|
|
Line 578: Line 806:
| rowspan="11" |'''Oncologic'''
| rowspan="11" |'''Oncologic'''
|[[Acute lymphoblastic leukemia]]
|[[Acute lymphoblastic leukemia]]
|
|
|
|
|
|
Line 583: Line 813:
|-
|-
|[[acute myeloid leukemia]]
|[[acute myeloid leukemia]]
|
|
|
|
|
|
Line 588: Line 820:
|-
|-
|[[acute promyelocytic leukemia]]
|[[acute promyelocytic leukemia]]
|
|
|
|
|
|
Line 593: Line 827:
|-
|-
|[[chronic lymphocytic leukaemia]]
|[[chronic lymphocytic leukaemia]]
|
|
|
|
|
|
Line 598: Line 834:
|-
|-
|[[chronic myeloid leukaemia]]
|[[chronic myeloid leukaemia]]
|
|
|
|
|
|
Line 603: Line 841:
|-
|-
|[[hairy cell leukaemia]]
|[[hairy cell leukaemia]]
|
|
|
|
|
|
Line 608: Line 848:
|-
|-
|[[hepatosplenic T-cell lymphoma]]
|[[hepatosplenic T-cell lymphoma]]
|
|
|
|
|
|
Line 613: Line 855:
|-
|-
|[[lymphoma]]
|[[lymphoma]]
|
|
|
|
|
|
Line 618: Line 862:
|-
|-
|[[myeloma]]
|[[myeloma]]
|
|
|
|
|
|
Line 623: Line 869:
|-
|-
|[[Non-Hodgkins lymphoma]]
|[[Non-Hodgkins lymphoma]]
|
|
|
|
|
|
Line 628: Line 876:
|-
|-
|[[paraneoplastic syndrome]]
|[[paraneoplastic syndrome]]
|
|
|
|
|
|
Line 634: Line 884:
| rowspan="2" |'''Overdose/Toxicity'''
| rowspan="2" |'''Overdose/Toxicity'''
|[[ethanol]]
|[[ethanol]]
|
|
|
|
|
|
Line 639: Line 891:
|-
|-
|[[arsenic trioxide]]
|[[arsenic trioxide]]
|
|
|
|
|
|
Line 645: Line 899:
|'''Pulmonary'''
|'''Pulmonary'''
|[[Acute respiratory distress syndrome]]
|[[Acute respiratory distress syndrome]]
|
|
|
|
|
|
Line 651: Line 907:
|'''Renal/Electrolyte'''
|'''Renal/Electrolyte'''
|[[hemolytic uremic syndrome]]
|[[hemolytic uremic syndrome]]
|
|
|
|
|
|
Line 657: Line 915:
| rowspan="10" |'''Rheumatology/Immunology/Allergy'''
| rowspan="10" |'''Rheumatology/Immunology/Allergy'''
|[[Anticardiolipin syndrome]]
|[[Anticardiolipin syndrome]]
|
|
|
|
|
|
Line 662: Line 922:
|-
|-
|[[antiphospholipid syndrome]]
|[[antiphospholipid syndrome]]
|
|
|
|
|
|
Line 667: Line 929:
|-
|-
|[[autoimmune lymphoproliferative syndrome type 1]]
|[[autoimmune lymphoproliferative syndrome type 1]]
|
|
|
|
|
|
Line 672: Line 936:
|-
|-
|[[autoimmune lymphoproliferative syndrome type 2]]
|[[autoimmune lymphoproliferative syndrome type 2]]
|
|
|
|
|
|
Line 677: Line 943:
|-
|-
|[[Factor H|complement factor H deficiency]]
|[[Factor H|complement factor H deficiency]]
|
|
|
|
|
|
Line 682: Line 950:
|-
|-
|[[Evans syndrome]]
|[[Evans syndrome]]
|
|
|
|
|
|
Line 687: Line 957:
|-
|-
|[[immunodysregulation polyendocrinopathy and enteropathy, X-linked]]
|[[immunodysregulation polyendocrinopathy and enteropathy, X-linked]]
|
|
|
|
|
|
Line 692: Line 964:
|-
|-
|[[macrophage-activation syndrome]]
|[[macrophage-activation syndrome]]
|
|
|
|
|
|
Line 697: Line 971:
|-
|-
|[[neonatal alloimmune thrombocytopenia]]
|[[neonatal alloimmune thrombocytopenia]]
|
|
|
|
|
|
Line 702: Line 978:
|-
|-
|[[systemic lupus erythematosus]]
|[[systemic lupus erythematosus]]
|
|
|
|
|
|
Line 708: Line 986:
|'''Miscellaneous'''
|'''Miscellaneous'''
|[[Snakebites]]
|[[Snakebites]]
|
|
|
|
|
|

Revision as of 16:52, 28 July 2018

Thrombocytopenia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thrombocytopenia from other Diseases

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thrombocytopenia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thrombocytopenia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thrombocytopenia differential diagnosis

CDC on Thrombocytopenia differential diagnosis

Thrombocytopenia differential diagnosis in the news

Blogs on Thrombocytopenia differential diagnosis

Directions to Hospitals Treating Thrombocytopenia

Risk calculators and risk factors for Thrombocytopenia differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Farbod Zahedi Tajrishi, M.D.

Overview

Thrombocytopenia has a broad range of potential causes. While a good history and physical examination can be helpful to diagnose some of these causes such as drug-induced thrombocytopenia, they usually don't suffice and further evaluation is often needed. There are also some useful points that may guide the physician to an appropriate diagnosis. For example, asymptomatic, isolated thrombocytopenia most probably suggests ITP, while thrombocytopenia in critically ill, hospitalized patients is usually suggestive of iatrogenic causes (eg. dilution), platelet consumption, bone marrow suppression from infection/sepsis, or even drug-induced thrombocytopenia. One should consider however, that a wide variety of other conditions such as autoimmune disorders, nutrient deficiencies, thrombotic microangiopathies could all as well cause thrombocytopenia.

Differential Diagnosis

Category Disease History and symptoms Laboratory findings Pathology
WBC changes RBC changes other findings
Cardiovascular endocarditis
pulmonary embolism
Chemical/poisoning Strontium-89
zinc
Dermatologic Cholesterol embolism
Elejalde syndrome
Griscelli syndrome type 1
neuroectodermal melanolysosomal disease
Ear Nose Throat Alport syndrome
Arias oculootoradial syndrome
Epstein's syndrome
Fechtner syndrome
Endocrine Immunodysregulation polyendocrinopathy and enteropathy, X-linked
Gastroenterologic Dibasic aminoaciduria type 2
liver failure
Niemann-Pick disease type b
portal hypertension
Genetic Aicardi-Goutieres syndrome
Chediak-Higashi disease
complement factor H deficiency
Elejalde syndrome
Fanconi anaemia
Fechtner syndrome
Griscelli syndrome type 1
holocarboxylase synthase deficiency
iminodipeptiduria
Jacobsen syndrome
MELAS
Omenn syndrome
TAR syndrome
X-linked hyperimmunoglobulin M syndrome
Hematologic Acquired pure megakaryocytic aplasia
aplastic anemia
Bernard-Soulier syndrome
congenital amegakaryocytic thrombocytopenia (CAMT)
disseminated intravascular coagulation
Epstein's syndrome
familial histiocytic reticulosis
Gasser syndrome
GATA1-related cytopenia
Glanzmann's thrombasthenia
grey platelet syndrome
hemolytic uremic syndrome
histiocytosis X
hypersplenism
idiopathic thrombocytopenic purpura
Jacobsen syndrome
Kasabach-Merritt syndrome
May-Hegglin anomaly
Moschcowitz syndrome
myelodysplastic syndrome
myelofibrosis
neonatal alloimmune thrombocytopenia
pancytopenia
Paris-Trousseau thrombocytopenia
paroxysmal nocturnal hemoglobinuria
post-transfusion purpura
radial aplasia-thrombocytopenia syndrome
Sebastian platelet syndrome
Shwachman-Diamond syndrome
thrombotic thrombocytopenic purpura
Von Willebrand disease, platelet type
Werlhof disease
Wiskott-Aldrich syndrome
Iatrogenic Cardiac bypass
chemotherapy
intra-aortic balloon pump placement
massive blood transfusion
radiation therapy
Infectious diseases Congenital syphilis
cytomegalovirus
Dengue fever
ehrlichiosis
Epstein-Barr virus
hantavirus
hepatitis C
HIV
human granulocytic ehrlichiosis
human monocytotropic ehrlichiosis
lassa fever
leptospirosis
malaria
measles
mumps
mycoplasma pneumonia
Oklahoma tick fever
parvovirus
Q fever
rubella
sepsis
tick-borne encephalitis
toxic shock syndrome (staphylococcal)
varicella
visceral leishmaniasis
Nutritional/Metabolic folate deficiency
Gaucher disease
holocarboxylase synthase deficiency
iminodipeptiduria
iron deficiency
isovaleric acidaemia
methylmalonic aciduria type 2
platelet glycoprotein 4 deficiency
platelet glycoprotein Ib deficiency
prolidase deficiency
propionyl-CoA carboxylase deficiency
sea blue histiocytosis
sitosterolemia
vitamin B12 deficiency
Obstetric/Gynecologic Eclampsia, pre-eclampsia
HELLP syndrome
Oncologic Acute lymphoblastic leukemia
acute myeloid leukemia
acute promyelocytic leukemia
chronic lymphocytic leukaemia
chronic myeloid leukaemia
hairy cell leukaemia
hepatosplenic T-cell lymphoma
lymphoma
myeloma
Non-Hodgkins lymphoma
paraneoplastic syndrome
Overdose/Toxicity ethanol
arsenic trioxide
Pulmonary Acute respiratory distress syndrome
Renal/Electrolyte hemolytic uremic syndrome
Rheumatology/Immunology/Allergy Anticardiolipin syndrome
antiphospholipid syndrome
autoimmune lymphoproliferative syndrome type 1
autoimmune lymphoproliferative syndrome type 2
complement factor H deficiency
Evans syndrome
immunodysregulation polyendocrinopathy and enteropathy, X-linked
macrophage-activation syndrome
neonatal alloimmune thrombocytopenia
systemic lupus erythematosus
Miscellaneous Snakebites

References

Template:WS Template:WH

Retrieved from "https://www.wikidoc.org/index.php?title=Thrombocytopenia_differential_diagnosis&oldid=1485995"